Multiple Doses of DM199 in Patients With Chronic Kidney Disease (REDUX)
Public ClinicalTrials.gov record NCT04123613. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-Center Open-label Investigation to Assess the Safety and Efficacy of Multiple Doses of DM199 in Patients With Chronic Kidney Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
An open-label, Phase II, multi-center study evaluating multiple doses of DM199 in participants with chronic kidney disease.
Study identification
- NCT ID
- NCT04123613
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 79 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 17, 2019 (Actual)
- Primary completion
- Mar 16, 2022 (Actual)
- Completion
- Mar 16, 2022 (Actual)
- Last update posted
- Mar 31, 2022
2019 – 2022
United States locations
- U.S. sites
- 14
- U.S. states
- 8
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Aventiv Research | Mesa | Arizona | 85210 | — |
| Amcis Research Center | Granada Hills | California | 91334 | — |
| IMD Clinical Trials Inc | Los Angeles | California | 90033 | — |
| Amicis Reserch Center | Northridge | California | 91324 | — |
| Innovative Healthcare Institute | Coral Springs | Florida | 33067 | — |
| Elixia at Florida Kidney Physicians-SE | Fort Lauderdale | Florida | 33308 | — |
| Pines Clinical Research-Hollywood | Hollywood | Florida | 33024 | — |
| Elixia at Florida Kidney Physicians | Temple Terrace | Florida | 33637 | — |
| Boise Kidney & Hypertension Institute | Meridian | Idaho | 83642 | — |
| Research by Design LLC | Chicago | Illinois | 60643 | — |
| New Orleans Center for Clinical Research, an AMR Company | New Orleans | Louisiana | 70119 | — |
| Elixia At Clincal Renal Associates | Upland | Pennsylvania | 19013 | — |
| Nephrotex Research Group, LLC | Dallas | Texas | 75231 | — |
| RDRI | DeSoto | Texas | 75115 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04123613, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 31, 2022 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04123613 live on ClinicalTrials.gov.